ResMed Inc. (NYSE:RMD) Q1 2025 Earnings Conference Call October 24, 2024 4:30 PM ET
Company Participants
Amy Wakeham – Chief Investor Relations Officer
Michael Farrell – Chairman and Chief Executive Officer
Brett Sandercock – Chief Financial Officer
Conference Call Participants
Laura Sutcliffe – UBS
Craig Wong-Pan – RBC
David Low – JPMorgan
Saul Hadassin – Barrenjoey Capital
Anthony Petrone – Mizuho
Daniel Hurren – MST Marquee
Mike Matson – Needham & Company
Brett Fishbin – KeyBanc Capital Markets
Suraj Kalia – Oppenheimer
Lyanne Harrison – Bank of America
Andrew Paine – CLSA
Operator
Hello, and welcome to the Q1 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I’ll be your operator for today’s call. At this time, all participants are in a listen-only mode. Later, we’ll conduct a question-and-answer session. Please note this conference call is being recorded.
I’ll now turn the call over to Amy Wakeham, Chief Investor Relations Officer. Amy, you may begin.
Amy Wakeham
Great. Thank you, Kevin. Hi, everyone, and welcome to ResMed’s first quarter fiscal year 2025 earnings call. As Kevin said, we are live webcasting this call and the replay will be available on the Investor Relations section of our corporate website later today. Our earnings press release and presentation are both available online now.
During today’s call, we will discuss several non-GAAP measures that we believe provide helpful information for investors. This information is not intended to be considered in isolation or as a substitute for the reported GAAP financial information. We encourage you to review the supporting schedules in today’s earnings press release to reconcile these non-GAAP measures with the GAAP reported numbers.
In addition, our discussion today will include forward-looking statements, including but not limited to expectations about our future financial and operating performance. We make these statements based on
Read the full article here